\-\ Texto\\:\\ \ \(0\)\
\-\ total\\ protein\\ in\\ 24\\ hours\\ 4598\\ \\(42\\-225mg\\/24h\\)\ \(0\)\
\-\ ldh\\ 772\\ \\(313\\-618\\)\ \(0\)\
\-\ alk\\ phos\\ 298\\ \\(38\\-126\\)\ \(0\)\
\-\ serum\\ sodium\\ 131\\ \\(137\\-148\\)\ \(0\)\
\-\ esr\\ 82\ \(0\)\
\-\ pt\\ was\\ given\\ dilantin\\ and\\ magnesium\\ until\\ after\\ delivery\\ of\\ child\\.\\ follow\\ up\\ mri\\ was\\ performed\\ 2\\ months\\ later\\.\ \(0\)\
\-\ on\\ the\\ first\\ set\\ of\\ images\\ there\\ is\\ subcortical\\ white\\ matter\\ t2\\ and\\ flair\\ hyperintensity\\ in\\ the\\ occipital\\ and\\ parietal\\ lobes\\ in\\ the\\ distribution\\ of\\ the\\ posterior\\ circulation\\.\\ there\\ is\\ also\\ abnormal\\ fluid\\ signal\\ in\\ the\\ anterior\\ cerebral\\/middle\\ cerebral\\ artery\\ watershed\\ area\\ without\\ abnormal\\ gray\\ matter\\ signal\\.\\ there\\ is\\ mild\\ increased\\ signal\\ on\\ diffusion\\ weighted\\ imaging\\ in\\ the\\ areas\\ of\\ high\\ t2\\ signal\\ intensity\\,\\ but\\ no\\ associated\\ adc\\ abnormality\\ to\\ suggest\\ infarct\\.\ \(0\)\
\-\ posterior\\ reversible\\ leukoencephalopathy\\ syndrome\\ \\(pres\\)\ \(0\)\
\-\ edema\\ from\\ posterior\\ reversible\\ leukoencephalopathy\ \(0\)\
\-\ ischemia\\ related\\ changes\\ secondary\\ to\\ seizure\ \(0\)\
\-\ demyelinating\\ process\ \(0\)\
\-\ posterior\\ circulation\\ ischemia\\ or\\ infarction\ \(0\)\
\-\ 20\\ y\\.o\\.\\ pregnant\\ woman\\ \\(g1p0\\)\\ with\\ 36wga\\ intra\\ uterine\\ pregnancy\\ and\\ eclampsia\\ with\\ severe\\ headaches\\,\\ seizure\\ activity\\ and\\ visual\\ disturbance\\.\ \(0\)\
\-\ delivery\\ of\\ child\\ caused\\ remission\\ of\\ clinical\\ symptoms\\ and\\ the\\ follow\\ up\\ mri\\ had\\ interval\\ resolution\\ of\\ all\\ abnormalities\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ leukoencephalopathy\\:\\ 0\\.20144797742099446\ \(0\)\
\-\ reversible\\:\\ 0\\.1934021450403418\ \(0\)\
\-\ signal\\:\\ 0\\.18960529092620856\ \(0\)\
\-\ circulation\\:\\ 0\\.18112655878769637\ \(0\)\
\-\ posterior\\:\\ 0\\.17296074938356473\ \(0\)\
\-\ delivery\\:\\ 0\\.15718107441687657\ \(0\)\
\-\ ischemia\\:\\ 0\\.14484275750627604\ \(0\)\
\-\ seizure\\:\\ 0\\.13916373479494304\ \(0\)\
\-\ child\\:\\ 0\\.13843530950115288\ \(0\)\
\-\ 4598\\:\\ 0\\.13372523605614423\ \(0\)\
\-\ 772\\:\\ 0\\.13372523605614423\ \(0\)\
\-\ 36wga\\:\\ 0\\.13372523605614423\ \(0\)\
\-\ matter\\:\\ 0\\.12733799394380776\ \(0\)\
\-\ 298\\:\\ 0\\.11762089280852742\ \(0\)\
\-\ magnesium\\:\\ 0\\.11762089280852742\ \(0\)\
\-\ watershed\\:\\ 0\\.11762089280852742\ \(0\)\
\-\ the\\:\\ 0\\.11679536219884742\ \(0\)\
\-\ cerebral\\:\\ 0\\.11586423942349958\ \(0\)\
\-\ of\\:\\ 0\\.1145472924219472\ \(0\)\
\-\ dilantin\\:\\ 0\\.11013279962983305\ \(0\)\
\-\ eclampsia\\:\\ 0\\.10873566629499501\ \(0\)\
\-\ g1p0\\:\\ 0\\.10418916569886527\ \(0\)\
\-\ in\\:\\ 0\\.10400866243366458\ \(0\)\
\-\ and\\:\\ 0\\.10367325034479262\ \(0\)\
\-\ pres\\:\\ 0\\.1032431081061971\ \(0\)\
\-\ disturbance\\:\\ 0\\.1032431081061971\ \(0\)\
\-\ remission\\:\\ 0\\.1015165495609106\ \(0\)\
\-\ abnormal\\:\\ 0\\.10047453972448349\ \(0\)\
\-\ there\\:\\ 0\\.09981540923412492\ \(0\)\
\-\ sodium\\:\\ 0\\.09729947417522933\ \(0\)\
\-\ t2\\:\\ 0\\.09621681851698231\ \(0\)\
\-\ set\\:\\ 0\\.09612614373632987\ \(0\)\
\-\ demyelinating\\:\\ 0\\.09176879163479085\ \(0\)\
\-\ ldh\\:\\ 0\\.09095420402599849\ \(0\)\
\-\ subcortical\\:\\ 0\\.09018250980536209\ \(0\)\
\-\ follow\\:\\ 0\\.09015597373102942\ \(0\)\
\-\ 131\\:\\ 0\\.08841424766169692\ \(0\)\
\-\ pregnant\\:\\ 0\\.08776263794479658\ \(0\)\
\-\ alk\\:\\ 0\\.08744738267739739\ \(0\)\
\-\ phos\\:\\ 0\\.08654036320352186\ \(0\)\
\-\ adc\\:\\ 0\\.08625008035262736\ \(0\)\
\-\ mri\\:\\ 0\\.085845311379603\ \(0\)\
\-\ 82\\:\\ 0\\.08514322986868382\ \(0\)\
\-\ hyperintensity\\:\\ 0\\.08338708744868799\ \(0\)\
\-\ up\\:\\ 0\\.08272649220854822\ \(0\)\
\-\ uterine\\:\\ 0\\.07808790036863732\ \(0\)\
\-\ protein\\:\\ 0\\.07760192862814753\ \(0\)\
\-\ esr\\:\\ 0\\.07652697979976136\ \(0\)\
\-\ interval\\:\\ 0\\.07566444838717402\ \(0\)\
\-\ serum\\:\\ 0\\.07498252055203478\ \(0\)\
\-\ occipital\\:\\ 0\\.07155245449049599\ \(0\)\
\-\ gray\\:\\ 0\\.07155245449049599\ \(0\)\
\-\ visual\\:\\ 0\\.07134303942978058\ \(0\)\
\-\ flair\\:\\ 0\\.07113657397518065\ \(0\)\
\-\ distribution\\:\\ 0\\.07093297618918537\ \(0\)\
\-\ diffusion\\:\\ 0\\.07043601995590504\ \(0\)\
\-\ intra\\:\\ 0\\.07005023966665472\ \(0\)\
\-\ lobes\\:\\ 0\\.06976742436810869\ \(0\)\
\-\ until\\:\\ 0\\.06958186739747152\ \(0\)\
\-\ infarct\\:\\ 0\\.06958186739747152\ \(0\)\
\-\ is\\:\\ 0\\.06869902279656892\ \(0\)\
\-\ total\\:\\ 0\\.0685153022152636\ \(0\)\
\-\ pregnancy\\:\\ 0\\.06842982789178924\ \(0\)\
\-\ suggest\\:\\ 0\\.06792719105198827\ \(0\)\
\-\ resolution\\:\\ 0\\.06784506868065923\ \(0\)\
\-\ parietal\\:\\ 0\\.06752110400480289\ \(0\)\
\-\ caused\\:\\ 0\\.06704819831825158\ \(0\)\
\-\ infarction\\:\\ 0\\.06564401578638274\ \(0\)\
\-\ hours\\:\\ 0\\.06373071834706048\ \(0\)\
\-\ related\\:\\ 0\\.0635463284322691\ \(0\)\
\-\ process\\:\\ 0\\.06271524244813577\ \(0\)\
\-\ weighted\\:\\ 0\\.06237299799336965\ \(0\)\
\-\ headaches\\:\\ 0\\.06237299799336965\ \(0\)\
\-\ activity\\:\\ 0\\.06139174517384695\ \(0\)\
\-\ abnormality\\:\\ 0\\.06082290182769508\ \(0\)\
\-\ abnormalities\\:\\ 0\\.060571458185144915\ \(0\)\
\-\ pt\\:\\ 0\\.06017790958360731\ \(0\)\
\-\ later\\:\\ 0\\.05984201392284719\ \(0\)\
\-\ intensity\\:\\ 0\\.0593751335376983\ \(0\)\
\-\ 24\\:\\ 0\\.059283515708568366\ \(0\)\
\-\ was\\:\\ 0\\.05828420819630307\ \(0\)\
\-\ given\\:\\ 0\\.05752148207782589\ \(0\)\
\-\ areas\\:\\ 0\\.05677160851716801\ \(0\)\
\-\ first\\:\\ 0\\.05642936406240187\ \(0\)\
\-\ white\\:\\ 0\\.0551695507476218\ \(0\)\
\-\ area\\:\\ 0\\.054169699314976484\ \(0\)\
\-\ 20\\:\\ 0\\.053945896419037895\ \(0\)\
\-\ clinical\\:\\ 0\\.052993890842947464\ \(0\)\
\-\ severe\\:\\ 0\\.05293454337345018\ \(0\)\
\-\ artery\\:\\ 0\\.051933064902128116\ \(0\)\
\-\ changes\\:\\ 0\\.05053593156729008\ \(0\)\
\-\ on\\:\\ 0\\.050508841453992\ \(0\)\
\-\ syndrome\\:\\ 0\\.05041074886849587\ \(0\)\
\-\ edema\\:\\ 0\\.04987230150945948\ \(0\)\
\-\ all\\:\\ 0\\.04977649198575341\ \(0\)\
\-\ secondary\\:\\ 0\\.04956318305694607\ \(0\)\
\-\ performed\\:\\ 0\\.04946936638508215\ \(0\)\
\-\ months\\:\\ 0\\.048673114535041306\ \(0\)\
\-\ fluid\\:\\ 0\\.04827985922398586\ \(0\)\
\-\ high\\:\\ 0\\.04752365004736115\ \(0\)\
\-\ mild\\:\\ 0\\.04740132273155214\ \(0\)\
\-\ anterior\\:\\ 0\\.04668805098358005\ \(0\)\
\-\ symptoms\\:\\ 0\\.045751665977830334\ \(0\)\
\-\ increased\\:\\ 0\\.0452172639697288\ \(0\)\
\-\ without\\:\\ 0\\.04410596149822033\ \(0\)\
\-\ associated\\:\\ 0\\.04407356633599049\ \(0\)\
\-\ imaging\\:\\ 0\\.04394469689112561\ \(0\)\
\-\ woman\\:\\ 0\\.043549130391952046\ \(0\)\
\-\ to\\:\\ 0\\.04180925001545196\ \(0\)\
\-\ had\\:\\ 0\\.04166213848772241\ \(0\)\
\-\ but\\:\\ 0\\.04134980382461316\ \(0\)\
\-\ after\\:\\ 0\\.04056502384413776\ \(0\)\
\-\ also\\:\\ 0\\.039332055006270766\ \(0\)\
\-\ images\\:\\ 0\\.038679427210754666\ \(0\)\
\-\ from\\:\\ 0\\.03320998409367371\ \(0\)\
\-\ with\\:\\ 0\\.03274735268624977\ \(0\)\
\-\ or\\:\\ 0\\.029089615780886844\ \(0\)\
\-\ no\\:\\ 0\\.027191998390999655\ \(0\)\
